Leiden, Utrecht October 2019 MIMETAS and Hubrecht Organoid Technology (HUB) announce that they entered into a strategic collaboration to market organoid models on a Chip. The agreement includes a license to MIMETAS to market HUB Organoids in an assay ready format, as well as a collaborative effort to develop disease-specific models.
{iframe}https://mimetas.com/mimetas-news/mimetas-and-hubrecht-organoid-technology-develop-and-market-organoids-chip{/iframe}